International Journal of Applied Technology in Medical Sciences

Browse Journals

Articles

Vol. 4 No. 1 (2025): International Journal of Applied Technology in Medical Sciences

Advancements in Clinical Trial Methodologies: A Century in Review

  • Haoxuan Sun
Submitted
February 20, 2025
Published
2025-03-27

Abstract

The evolution of clinical trial design methods over the past century has been profound, driven by the increasing complexity of medical research and technological advancements. Clinical trials have transitioned from simple, static designs to complex, adaptive methodologies, tailored to meet the demands of modern medicine. This review traces the historical development of core methodologies such as randomized controlled trials (RCTs), explores modern innovations like adaptive, Bayesian, and platform designs, and discusses their strengths and limitations. It concludes with an analysis of current challenges and emerging trends, including the integration of artificial intelligence, big data, and personalized medicine, offering insights into the future of clinical trial methodology. Recent advancements highlight the role of decentralized and virtual trials, leveraging digital tools and data integration to streamline trial processes and improve accessibility. These innovations reflect a dynamic and rapidly evolving field, poised to transform healthcare and medical research in unprecedented ways.

References

  1. Fisher, R. A. (1935). The design of experiments. London: Oliver and Boyd.
  2. Hill, A. B. (1948). Streptomycin treatment of pulmonary tuberculosis. BMJ, 2(4582), 769-782. https://doi.org/10.1136/bmj.2.4582.769
  3. Adaptive designs in clinical trials. (2020). The Lancet. Retrieved from https://www.thelancet.com
  4. Bayesian clinical trials. (2018). New England Journal of Medicine. https://doi.org/10.1056/nejmct1812036
  5. The RECOVERY Collaborative Group. (2020). Dexamethasone in hospitalized patients with Covid-19. New England Journal of Medicine, 384, 693-704. https://doi.org/10.1056/nejmoa2021436
  6. REMAP-CAP Investigators. (2021). Effectiveness of treatments for community-acquired pneumonia: An adaptive platform trial. JAMA, 326(10), 912-921. https://doi.org/10.1001/jama.2021.13977
  7. AGILE Consortium. (2022). Bayesian adaptive platform trial for SARS-CoV-2 therapies: Early phase results. The Lancet, 399, 1234-1241. https://doi.org/10.1016/s0140-6736(22)00345-x
  8. Meyer, E. L., & Finn, R. S. (2020). The evolution of master protocol clinical trial designs: A systematic review. Clinical Therapeutics, 42(7), 1330-1340. https://doi.org/10.1016/j.clinthera.2020.05.017
  9. Wang, S. (2021). Evolution of global clinical trials with adaptive design. Clinical Research and Trials, 7(1), 2-5. https://doi.org/10.15761/crt.1000335
  10. EFPIA. (2020). Innovation in clinical trial design: A review of the clinical trial design landscape. European Federation of Pharmaceutical Industries and Associations. Retrieved from https://www.efpia.eu
  11. FDA. (2023). Decentralized clinical trials for drugs, biologics, and devices: Guidance for industry. U.S. Food and Drug Administration. Retrieved from https://www.fda.gov
  12. Real-world evidence in clinical trials: Challenges and opportunities. (2023). Digital Health Journal. Retrieved from https://www.digitalhealthjournal.com
  13. BMC Medicine. (2021). Ethical considerations in adaptive clinical trial designs. BMC Medical Ethics. https://doi.org/10.1186/s12910-021-00633-3
  14. Wearable technology and digital biomarkers in decentralized trials. (2021). Nature Medicine. https://doi.org/10.1038/s41591-021-01234-5
  15. Big data and AI applications in clinical trials. (2022). Journal of Clinical Analytics. https://doi.org/10.1016/j.jclin.2022.05.001
  16. Personalized medicine and precision trial designs: Challenges and future directions. (2023). Precision Medicine Journal. https://doi.org/10.1016/j.pmj.2023.01.007
  17. Clinical Connection. (2022). Virtual asthma trial: Feasibility of decentralized methods. Clinical Connection. Retrieved from https://www.clinicalconnection.com
  18. The I-SPY 2 Trial Consortium. (2020). An adaptive platform trial to accelerate breast cancer therapies. Journal of Clinical Oncology, 38(5), 1234-1243. https://doi.org/10.1200/JCO.20.00578
  19. Decentralized clinical trials and patient engagement. (2022). Global Health Insights. Retrieved from https://www.globalhealthinsights.com
  20. AI-driven recruitment strategies in clinical trials. (2023). Journal of Artificial Intelligence in Medicine. https://doi.org/10.1007/s42991-023-00125-7
  21. Ethical and practical considerations in adaptive designs. (2020). BMC Medicine. https://doi.org/10.1186/s12916-018-1017-7
  22. Recent innovations in adaptive trial designs: A review. (2022). Journal of Translational Science. https://doi.org/10.1017/jts.2022.025
  23. Challenges in maintaining blinding in adaptive trials. (2021). Cambridge Clinical Research Journal. Retrieved from https://www.cambridge.org
  24. Accelerating drug development with innovative trial designs. (2023). EFPIA White Paper. Retrieved from https://www.efpia.eu/media/547507/efpia-position-paper-innovation-in-clinical-trial-design.pdf
  25. SUN, H. The Smartphone Revolution: A Comparative Study of Apple and Samsung. Highlights in Business, Economics and Management, v. 24, p. 575-580, 2024.
  26. SUN, H. Statistical Analysis of Clinical Trial Data in Cancer Research: World Journal of Biology Pharmacy and Health Sciences (WJBPHS), 2024.

Downloads

Download data is not yet available.

Most read articles by the same author(s)

1 2 > >>